Director, R&D Tech Risk & Compliance Partnerships

GSK; Irvine; Hybrid; GBP 120,000 - 180,000; Full time

Job summary

GSK is seeking a Director of Technology Risk & Compliance Business Partners for R&D, based in the UK with hybrid working, focused on Cambridge and Ware sites. You will translate cyber risk strategy into delivery plans, lead a risk-aware culture and oversee GxP regulatory technology in a rapidly evolving landscape.

You will own the relationship with R&D leadership, guide risk posture, manage audits, and collaborate across the Cyber Security Office to drive effective controls and timely CAPAs.

Qualifications

• Demonstrated experience in cyber risk, technology risk or information security governance.
• Working knowledge of risk assessment and risk register management.
• Senior stakeholder engagement with proven leadership capabilities.
• Experience in cyber security end-to-end ownership of a capability.

Responsibilities

• Own the cyber risk and compliance relationship for the R&D area, including Cambridge and Ware.
• Lead and develop the team, set priorities and manage performance.
• Report capability performance and risk to CSO leadership and governance forums.
• Embed security requirements at the start of initiatives and ensure regulatory alignment.
• Coordinate risk governance activities and CAPA tracking with business lines.

Skills

Cyber security governance

Risk assessment

Stakeholder engagement

Leadership

Regulatory knowledge

Education

Degree in a relevant discipline

Tools

ServiceNow

Job description

GSK is seeking a Director of Technology Risk & Compliance Business Partners for R&D, based in the UK with hybrid working, focused on Cambridge and Ware sites. You will translate cyber risk strategy into delivery plans, lead a risk-aware culture and oversee GxP regulatory technology in a rapidly evolving landscape.

You will own the relationship with R&D leadership, guide risk posture, manage audits, and collaborate across the Cyber Security Office to drive effective controls and timely CAPAs.